Working… Menu

Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma (JAZZ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03868943
Recruitment Status : Recruiting
First Posted : March 11, 2019
Last Update Posted : February 5, 2021
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Wake Forest University Health Sciences

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : January 30, 2023